drugset / Trial / NCT02129322
Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is designed to investigate the effect of adjuvant therapy by Sorafenib, Oxaliplatin and S-1 to prevent the tumor recurrence for hepatocellular carcinoma after liver transplantation
Timeline
- Start
- 2015-07
- Primary completion
- 2017-06
- Completion
- 2019-12
Outcome
Outcome not reported
Stopped (Enrollment): “patients not enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | S-1 | Small molecule | — | — |
| Subject | Sorafenib | Small molecule | — | — |